Hemostemix Closes Sale of 23rd ACP-01 Therapy Convertible Debenture
Newsfile·2025-07-23 12:55
Hemostemix Closes Sale of 23rd ACP-01 Therapy Convertible DebentureJuly 23, 2025 8:55 AM EDT | Source: Hemostemix Inc.Calgary, Alberta--(Newsfile Corp. - July 23, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or "HEM"), an autologous angiogenic stem cell therapy company that has safely treated 498 patients for various forms of cardiovascular disease, including peripheral arterial disease, chronic limb threatening ischemia, non ischemic dilated cardiomyopathy, isc ...